Um [72] and Bui et al. [64] outlined Bcl-2 overexpression in prostate cancer, breast cancer, melanomas, small cell lung carcinomas, glioma, neuroblastoma, colorectal cancer and hepatocarcinoma cells. Here, BCL2 is linked to colorectal cancer.